Arkolith/Insider Trading/COAG/Form 4

Ra Capital Management, L.P.

10% OwnerHemab Therapeutics Holdings, Inc. (COAG) · full profile →Form 4 · filed May 11, 2026
Net Buying
Open-Market Buys
$1.3M
Open-Market Sells
$0
Net Open-Market Flow
$1.3M
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2026Buy(P)14K$24.47$346K6.3M
May 11, 2026Buy(P)26K$25.00$643K6.4M
May 8, 2026Buy(P)1K$24.98$37K6.3M
May 7, 2026Buy(P)8K$24.34$193K6.3M
May 7, 2026Buy(P)2K$24.95$50K6.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000475) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML